MedPath

enGene

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
$288.4M
Website

Current Endpoints of Clinical Trials in Ulcerative Colitis

Christopher Ma, Brian Feagan, Vipul Jairath, Reena Khanna, Parambir S. Dulai, and William J Sandborn disclose various financial relationships with pharmaceutical companies and research organizations, including grants, personal fees, and other forms of compensation, outside their submitted work. Robert Battat and Parambir S. Dulai report no conflict of interest.
© Copyright 2025. All Rights Reserved by MedPath